製品安全データシート
Contents
1. N 6 GHS DNA 7 FR HBV 128 2011 6 22 7 332. EGO ss A a Ei
3. 5 NE 2 ebi 1B MM 1 3 1 1
4. Wn 2 2B 1A 5 33 DNA7 FR HBV 4 128 2011 6 22 6 33 3 1 2 H22 2 19
5. T m
6. 30 DNA 7 FR HBV 4 128 2011 6 22 31 33 12 GHS GHS 2 AN SO 08 10 0 1 m OECD TG405 i MMAS AOI 68 7 2A
7. 8 2 8C 15 8 DNA
8. 12 10 7 21 ECETOC TR 48 1998 20 20 32 3 48 LC
9. 1 3 1 1 Y PA LTN3 LD 794mg kg EHC 221
10. pH 4 6 4 8 8 4 8 6 0 65
11. 10 GHS GHS 10 0 1 m OECD TG405 7 21 MMAS A01 68 7 ECETOC TR 48 2 1998 2A
12. 10 T 12 3 32 DNA 7 n FR HBV 4 128 2011 6 22 33 33 14
13. O GHS 3 3
14. pH pH 7 2 80 8 28 a fF 1 2 6
15. 1 1 2 RR i RTECS 2 ya 1 2 2 LD 6200 15000mg kg bw DFGOT Vo1 12 1999 13 7g 13700mg kg 17 8g 17800mg kg 11 5g 11500mg kg Patty 5th 2005 9 8 11 6 ml kg bw 7938 9396 mg kg 15010 mg kg bw 7000 11000 mg kg bw 14 6 ml kg bw 11826 mg kg 7800 mg kg bw 11500 mg kg bw 11170 16710 mg kg
16. NTP DB Access on Apr 2006 ECETOC TR63 1995 CERI 2001 42 2002 ACGIH 7th 2005 in vivo in vivo ACGIH 2005 A4 NTP DB Access on May 2006 CEPRI 2001 30 2002 1B 1B
17. 4 1 20 6 lt 1 1 DNA7 FR HBV 128 2011 6 22 21 33 100C
18. 2 2 Nn Fin a o Fi NITE No 14 2005 1 1 LD 2 660mg kg 5 140mg kg 3 160mg kg 3 450mg kg 4 080mg kg 5 000mg kg LD 3 241mg k
19. 2mg m ACGIH 2009 STEL C 2mg my 2005 Img m ACGIH 2006 2009 ACGIH 2009 STEL 1000ppm 0 7 NB 2007 ACCIH 2007 2007 ACGIH 2007 TWA 2mg m STEL 6mg mi 2007 CE 10 ACGIH 12 ACGIH
20. 6 22 1 33 2 22 10 12 H21 3 DNA FR HBV L 128 2011 6 22 2 33
21. 00C 10 2 4 12
22. 5621 2278 10 12 LD 325mg kg 6 GHS 21 DNA 7
23. 10 12
24. i oO 1 oo 1 H22 2 19 GHS H21 3 HH8 3 31 GHS HI8 2 10 3 GHS
25. q E 2 RN 5 2B RN RK TR 2 ON 3 DNA FR HBV 4 128 2011 6 22 8 33
26. FR HBV 0 128 2011 6 22 16 33 2 MS 2009 10 12 12
27. LiOoH H O 41 96 CAS No 1310 66 3 0 42 0 97 1 712 C H OH 46 07 CAS No 64 17 5 13 DNA 7 n 7 FR HBV 4 128 2011 6 22 14 33 0 24 2 43 2 202 CH N CH COOH 292 24 CAS No 60 00 4 0 0012
28. UN SIDS 2009 DFGOT Vo1 12 1999 3 lt 26 DNA 7 np 7 FR HBV 128 2011 6 22 27 33 ACGIH 2001 1 3 Na Patty 5th 200 1 3 GR 200
29. 2009 NPD PATTY 5th 2001 1 Ae SIDS EN 50 200 mL SIDS 2009 DFGOTvo1 12 1999 1 SIDS 2009
30. DNA7 nm 7 FR HBV 5 128 2011 6 22 3 33 O
31. Ng GHS GHS IE DNA 7 n 2 FR HBV 4 128 2011 6 22 9 33
32. gt x 4 33 4
33. 2 O AG
34. ACGIH 7th 2001 DFGOTvo1 12 1999 BU C R35 0 063 1 0 7 0 125 A RE SIDS 2009 in vivo
35. in vivo SIDS 2009 in vivo SIDS 2009 in vivo in vitro Ames SIDS 2009 CHO K1 SIDS 2009 12 DFGOTvo1 12 22 DNA FR HBV YE 128 2011 6 22 23 33 1999
36. FE 1 2 8 1 1 CK6 9 281 3 4 1 81 2 F 17 6 6 9 1 1 680 2 6 1 8 1 1 22 661 22 17 33 DNA 7 n 7 FR HBV 4 pH
37. My ACGIH 7th 2001 SIDS 2009 LD 210mg kg 3 3 L C 0 96mg L 4H 3 3 1 8 H GHS 1B
38. q E E 1 DNA nm FR HBV 128 2011 6 22 10 33 ES
39. 19 DNA 7 FR HBV LE 128 2011 6 22 20 33 1 h 924
40. SIDS 2009 Na 1 2 168 LD 2 580 mg kg BUA 1995 5 5 LL GHS 2 CPRI NITE No 14 2004 Draize CERI oO N
41. 1A SIDS 2009 SIDS 2009 IARC vo1 44 1987 1A EN I RN 20 DFGOT Vo1 12 1999 Patty 5th 200 1
42. GHS 2A 12 GHS H23 3 15 GHS H22 7 2A
43. 1 00X109mg L PHYSPROP Database 2005 72 ErC 6mg L 2002 00 NR 2 2 BCF 123 i BOD 8 0 2 2 2 0 MM 96 LC 78 1mg boron L 447ng L 50000mg L
44. 12 DNA 7 n FR HBV 4 128 2011 6 22 13 33 GHS 2 NaOH 40 01 CAS No 1310 73 2 0 73 1 410
45. DNA 7 A FR HBV 4 128 2011 2009 2 2011 6 DNA F R HBV I IT 2 62 5 0120 292 832 FAX 03 5695 9234 290705 128 GHS H22 2 19 GHS 2
46. Draize OECD TG405 noderate irritating SIDS 2009 DFGOT Vo1 12 1999 1 3 MMAS Modified Maximum Average Score A01 24 0 ECETOCTR48 1998 7 ECETOC TR No 48 2 1998 2B 2 2 FGOT 1996 DFGOT 1996
47. GHS PS 1 11 Nl 8 128 2011 6 22 6 4 3
48. h h TE GHS DNA FR HBV i SNRSSRE
49. 15 57 2 18 2 9 319 320 61 2 68 1 1 1 60 1 405 1 1 408 10 408 12
50. 0 18 128 2011 3 8 681 1 08 1 1 22 1 8 21 E 6 I 3 681 220 22 18 33 1 0 DNA7 FR HBV 4 128 2011 6 22 19 33 gt
51. 2 1 2 2 GHS
52. ek Y KK YR Y e UN 8s 11 33 DNA 7 n FR HBV 4 128 2011 6 22 12 33 10 GHS H23 3 15 GHS H22 7
53. 3 DFGOT 996 1 6 HSDB 2003 2 90
54. 1 1 1 23 1 2 E DNA FR HBV 128 2011 6 22 24 33 B 0 2 1 i 1
55. DFGOT 1996 ACGIH 2001 DFGOT 1996 IUCLID 2000 in vivo SIDS 2009 IARC 1988 in vivo in vitro in vitro DFGOT Vo1 12 1999 SIDS 2009 NTP DB 2009 CHO 1 SIDS 200
56. 1 16 http www jaish gr jp index html 33
57. 16 9 pH DNA 7 n 7 FR HBV 4 128 2011 1 12 5 pH
58. DNA7 un 7 FR HBV 128 2011 6 22 GHS H22 2 19 GHS H21 3
59. GHS H21 3 H18 3 31 GHS HI8 2 10 GHS I
60. 1 IARC vo1 96 Access on Oct 2009 1ARC vo1 96 EU ONI OE i IARC vol 44 1987 RN MA IARC vol 44 1987 SIDS 2009 DFGOT Vol 12 1999 SIDS 2009
61. DNA FR HBV L 128 2011 6 22 GHS E E 1 1 2 x 1B 1
62. FR HBV 4 128 2011 6 22 22 33 2N 8 4N 16 6N 24 15 8 16 24 SIDS 2009 5 4 ACGIH 7th 2001 1 pH 12 0 05 w w Merck 14th 2006 0 5 4 0 5 55 61 SIDS 2009 EU C R35 1 1 29 2 SIDS 2009 pH 12 0 05 w w Merck 14th 2006 1
63. 2 1263 H B O 61 83 CAS No 10043 35 3 3 71 1 63 CH COO Zn 2H 0 219 5 CAS No 5970 45 6 0 022 0 0009 2 693 10 CHzCH0 CHLCH O n H n 10 646 86 CAS No 9002 93 1 0 01 1 00 7 172 T Q12 CH CHO CHLCHLO n H n 12 CAS N
64. 1 I 8
65. 2001 4 GHS 29 DNA 7 n FR HBV 4 128 2011 6 22 30 33 BHC 221 2001 20 slightly 1ess irritant 4 3 3 RTECS 1995
66. 40mg L 7 31 13 DNA 1 FR HBV 4 128 2011 6 22 32 33 96 LC gt 100mg L SIDS 2005 48 LC 5012mg L SIDS 2005 96 EC 1000mg L SIDS 2005
67. bw 7060 mg kg bw 8300 mg kg bw SIDS J 2009 LDLo 20 000 mg kg bw SIDS 2009 2 GHS LC 4 1 13 837ppmV SIDS 2009 4 1 63 000ppmV 4h DFGOT Vo1 12 1999 20 661ppmV 4h 66 181ppmV 4h 22 627ppmV 4h SIDS 2009 78 026ppmV 147 1 mg L 90 70 223ppmV 132 4 mg L ppmV 24 DNA7 FR HBV 128 2011 6 22 25 33 4 OECD TG 404 1 24 1 0 0 0 not irritating SIDS 2009
68. 9 ACGIH 43 ACGIH 2009 2 10 1 3 2 ACGIH 2009 25 DNA 7 FR HBV 4 128 2011 6 22 26 33 IARC 1 IARC Vo1 44 1987 2007
69. ITE No 14 2004 2 8 2B 2B 27 DNA FR HBV 128 2011 6 22 28 33 CERI NITE No 14 2004 in vivo in vivo in vivo EDTA 2Na CAS 6381 92 6 in vivo CERI NITE No 14 2004
70. g 5 5 GHS 4 24 72 2 2 ATSDR 1992 ACGIH 7th 2005 28 DNA FR HBV 128 2011 6 22 29 33 2A 2B 2A 2A 2B
71. o 9002 93 1 0 085 7 172 4 5 DNA FR HBV 4 128 2011 6 22 15 33 8
Download Pdf Manuals
Related Search